Daiichi Jitsugyo Co (8059) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
6 Nov, 2026Executive summary
H1 FY2027 net sales fell 15.2% YoY to ¥91,013M; operating profit declined 39.6% to ¥3,980M and profit attributable to owners fell 20.7% to ¥3,936M.
Full-year FY2027 forecasts remain unchanged, with net sales of ¥210,000M and operating profit of ¥12,000M.
Financial highlights
Gross profit was ¥16,854M versus ¥18,766M YoY; SG&A rose to ¥12,873M from ¥12,175M.
Ordinary profit declined 34.0% YoY to ¥4,422M; profit before income taxes was ¥5,792M versus ¥7,140M.
Net income attributable to owners was ¥3,936M, down 20.7% YoY; comprehensive income increased to ¥7,199M from ¥5,854M.
Gain on sale of investment securities was ¥1,369M, versus ¥434M in the prior-year period.
Outlook and guidance
FY2027 forecast: net sales ¥210,000M (-4.2% YoY), operating profit ¥12,000M (-12.4%), ordinary profit ¥12,400M (-13.6%), and owner-attributable profit ¥9,400M (-5.5%).
Full-year EPS forecast is ¥296.11; financial-result forecast has not been revised.
FY2027 dividend forecast is ¥125 per share, comprising ¥62 at interim and ¥63 at year-end; dividend forecast unchanged.
Latest events from Daiichi Jitsugyo Co
- Orders jumped 36.5% on AI demand, but sales and profits fell; comprehensive income surged.8059
Q1 2027 - Record profits and cash flow achieved despite lower sales; outlook remains cautious.8059
Q4 2026 - Record Q3 profits and strong segment growth support an upwardly revised full-year outlook.8059
Q3 2026 - Record Q2 sales and profits led to upward revisions in full-year forecasts and dividends.8059
Q2 2026 - Strong sales and profit growth, with robust outlook and improved equity ratio.8059
Q1 2025 - Record-high sales and profit, improved equity ratio, and strong full-year outlook.8059
Q2 2025 - Record Q3 sales and profits, stock split, and strong growth across all segments.8059
Q3 2025 - Record sales and profits, strong overseas growth, and a conservative outlook for next year.8059
Q4 2025 - Record Q1 sales and profits driven by Healthcare and Automobile, but outlook is slightly cautious.8059
Q1 2026